Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1999-05-26
2000-07-25
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514300, 544 582, 544120, 544238, 544295, 544357, 544405, 544 586, 546121, A61K 31497, A61K 31437, A61K 314375, C07D47104
Patent
active
060937173
ABSTRACT:
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: ##STR1## wherein Y.sup.1 and Y.sup.2 are independently selected from the group consisting of
REFERENCES:
patent: 5260307 (1993-11-01), Ackermann et al.
patent: 5405854 (1995-04-01), Ackermann et al.
patent: 5510369 (1996-04-01), Lumma et al.
patent: 5550131 (1996-08-01), Sugihara et al.
patent: 5744486 (1998-04-01), Sanderson et al.
patent: 5866573 (1999-02-01), Sanderson et al.
Naylor-Olsen Adel M.
Sanderson Philip E.
Bernhardt Emily
Merck & Co. , Inc.
Parr Richard S.
Winokur Melvin
LandOfFree
Imidazopyridine thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyridine thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridine thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1336816